Elevation Oncology Emerges from Stealth with $32.5M Series A to Develop Precision Medicines for Tumors Harboring Rare Genetic Driver Alterations

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2OY7uDP
via IFTTT